Share via:
A few days ago, Masimo sued U.S. Customs over its decision to let Apple resume selling the Apple Watch in the United States with the blood oxygen feature enabled. Now, the government agency has responded with a motion to dismiss the lawsuit. Here are the details.
When Apple released the Blood Oxygen feature on the Apple Watch, medical device maker Masimo sued over alleged patent infringement.
Over the years, the lawsuit dragged on and came to a head with an import…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
A few days ago, Masimo sued U.S. Customs over its decision to let Apple resume selling the Apple Watch in the United States with the blood oxygen feature enabled. Now, the government agency has responded with a motion to dismiss the lawsuit. Here are the details.
When Apple released the Blood Oxygen feature on the Apple Watch, medical device maker Masimo sued over alleged patent infringement.
Over the years, the lawsuit dragged on and came to a head with an import…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi
